第53回日本免疫学会学術集会

^○Tatsuya Hasegawa^1,2,3, Tomonori Oka^2,3, Heehwa G. Son^2,3, Valeria S. Oliver-Garcia^2,3, Marjan Azin^2,3, Thomas M. Eisenhaure⁴, David J. Lieb⁴, Nir Hacohen^2,4, Shadmehr Demehri^2,3 (1.MIRAI Technology Institute, Shiseido Co., Ltd., 2.Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, 3.Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, 4.Broad Institute of MIT and Harvard)

^○Daiki Takewaki^1,2, Yuya Kiguchi^2,3, Hiroaki Masuoka², Mallahalli Manu¹, Ben J E Raveney¹, Seiko Narushima⁴, Rina Kurokawa², Yusuke Ogata², Sachiko Miyake⁵, Wakiro Sato¹, Wataru Suda², Takashi Yamamura¹ (1.Department of Immunology, National Center of Neurology and Psychiatry, 2.Laboratory for Symbiotic Microbiome Sciences, RIKEN Center for Integrative Medical Sciences, 3.Department of Computational Biology and Medical Sciences, The University of Tokyo, 4.Laboratory for Mucosal Immunity, RIKEN Center for Integrative Medical Sciences, 5.Department of Immunology, Juntendo University)

^○Koichiro Suzuki¹, Takahiro Yamada^1,2, Yusuke Kinashi¹, Seiga Komiyama¹, Yuyo Ka³, Kayo Tomiyama³, Nanako Ushio-Watanabe⁴, Yoshifumi Nishikawa⁴, Koji Hase¹ (1.Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, 2.Department of Immunobiology, Yale School of Medicine, 3.Central Institute for Experimental Medicine and Life Science (CIEM), 4.National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine)

^○Mitsuru Arase¹, Mari Murakami^1,2, Kiyoshi Takeda^1,2 (1.Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, 2.WPI Immunology Frontier Research Center, Osaka University)

^○Daichi Mori¹, Yoshiyuki Goto^1,2,3,4 (1.Project for Host Microbial interactions in Symbiosis and Pathogenesis, Division of Molecular Immunology, Medical Mycology Research Center, Chiba university, 2.Division of Pandemic and Post-disaster Infectious Diseases, Research Institute of Disaster Medicine, Chiba University, Chiba, 3.Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, Chiba, 4.Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba)

^○Keishu Takahashi¹, Naoki Morita¹, Ryutaro Tamano¹, Peng Gao¹, Noriho Iida², Akira Andoh³, Hirotsugu Imaeda⁴, Ken Kurokawa⁵, Mayo Tsuboi⁵, Yoku Hayakawa⁵, Mitsuhiro Fujishiro⁵, Reiko Shinkura¹ (1.Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, The University of Tokyo, 2.Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa University, 3.Department of Medicine, Shiga University of Medical Science, 4.Department of Gastroenterology, Nagahama City Hospital, 5.Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo)

^○Yoshihiro Ito¹, Keitaro Fukuda^1,2, Michiko Koizumi-Kitajima¹, Masayuki Amagai^1,2 (1.Keio University, School of Medicine, Department of Dermatology, 2.Laboratory for Skin Homeostasis, IMS, RIKEN)

^○Satoshi Koga¹, Kazuyo Moro^1,2,3 (1.Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University, 2.Laboratory for Innate Immune Systems, RIKEN-IMS, 3.Laboratory for Innate Immune Systems, iFReC, Osaka University)

^○Ayaka Maki, Satoshi Matsumoto, Tomoaki Naito, Tetsuji Hori (Yakult Honsha Co., Ltd.)

^○Yutaka Kusumoto¹, Mayuko Hashimoto¹, Takahiro Adachi², Tsuneyasu Kaisho³, Michio Tomura¹ (1.Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, 2.Division of Precision Health, Medical Research Institute, Tokyo Medical and Dental University, 3.Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Graduate School of Medicine)

^○Kaori Ito, Kota Sakurai, Jahidul Islam, Tomonori Nochi (International Education and Research Center for Food and Agricultural Immunology, Graduate School of Agricultural Science, Tohoku University)

^○AN PING HUO^1,2,3, Cheng-Chung Wei^1,2,3, Pui-Ying Leong^1,2,3 (1.Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital Taichung, Taiwan, 2.Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, 3.School of Medicine, Chung Shan Medical University, Taichung, Taiwan)

^○Akihiko Murata, Koji Tokoyoda (Division of Immunology, Department of Molecular and Cellular Biology, School of Life Science, Faculty of Medicine, Tottori University)

^○Naoto Yoshino, Takashi Odagiri, Shizuma Ishikawa, Yasushi Muraki (Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University)

^○Meito Shibuya^1,2, Tomonori Machita¹, Tomoyuki Yamamoue¹, Satoshi Koike³, Kyousuke Kobayashi³, Seiya Yamayoshi^4,5, Hiroshi Kiyono^1,7,8, Kohtaro Fujihashi^1,6,9,10 (1.Department of Human Mucosal Vaccinology, Chiba University Hospital, and Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, 2.Vaccine R&D Laboratory, Vaccine Business Division, Shionogi & Co., Ltd., 3.Neurovirology Project, Department of Diseases & Infection, Tokyo Metropolitan Institute of Medical Science, 4.Div. Virology & Intern. Res. Ctr Infect. Dis., Inst. Med. Sci., and Univ. Tokyo Pandemic Prep., Infect. Adv. Res. Ctr (UTOPIA), The University of Tokyo, 5.The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, 6.Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, 7.Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA, 8.Future Medicine Education and Research Organization, Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, 9.Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, 10.Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham AL, USA)

^○Mayuko Hashimoto, Yutaka Kusumoto, Michio Tomura (Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University)

^○Yoshio Katsumata¹, Lisa Fujimura², Masahiro Okamoto³, Takashi Fumita¹, Akemi Sakamoto^2,4, Masahiko Hatano^2,4 (1.Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 2.Biomedical Research Center, Chiba University, 3.School of Medicine, Chiba University, 4.Department of Biomedical Science, Graduate School of Medicine, Chiba University)

Fumiya Okano¹, ^○Akihito Harusato^1,2, Yoshitaka Nakanishi³, Masashi Kato², Yoshito Itoh¹ (1.Kyoto Prefectural University of Medicine, 2.Nagoya University, 3.Kumamoto University)

^○Shohei James Asami¹, Hiroaki Masuoka², Wataru Suda², Hiroshi Ohno¹ (1.RIKEN Center for Integrative Medical Sciences Laboratory for Intestinal Ecosystem, 2.RIKEN Center for Integrative Medical Sciences Laboratory for Human Microbiome Sciences)

^○Yoonha Lee^1,2, Daiya Ohara¹, Hiroki Mukoyama¹, Yusuke Takeuchi¹, Hitomi Watanabe¹, Gen Kondoh¹, Keiji Hirota¹ (1.Institute for Life and Medical Sciences, Kyoto University, 2.Department of Hematology, Tohoku University Graduate School of Medicine)

^○Kimura Kimura Shunsuke, Shingo Kawai, Takahiro Yamada, Yutaka Nakamura, Koji Hase (Faculty of Pharmacy, Keio University)